Key Takeaways:
- NovaPump is an innovative startup that revolutionizes heart treatment methods by developing cutting-edge therapeutic solutions in non-invasive and percutaneous circulatory support.
- Based in Jena, Germany, the health-tech company leverages the PERKAT technique to offer innovative and cost-effective heart pump devices.
- The PERKAT technique adds to the existing IABP technique, offering a catheter-based, self-expanding, and high-performing circulatory support system.
In the realm of healthcare and technology, NovaPump is making headway in a transformative and pioneering direction in cardiac care. The German-based startup company specializes in the development and manufacture of Percutaneous Mechanical Circulatory Support Systems (pMCS). These breakthrough inventions are enhancing therapeutic solutions in the field of non-invasive and percutaneous circulation support.
Founded by Markus Ferrari and Ronald Reich, NovaPump has made significant strides in developing high-functioning, cost-effective cardiac support devices. Their revolutionary PERKAT (PERKutane KATheterpumpe) technique is paving the way for the next generation of circulatory support systems, granting acute patients the ability to support heart function non-invasively.
What truly sets NovaPump apart is their unique approach to developing modern heart treatment solutions. Specifically, it’s their implementation of the PERKAT technique. This unique method employs left and right heart pumps for acute heart patients, offering non-invasive and cost-effective treatment options. Unlike previously utilized methods, such as the intra aortic balloon pump with an estimated 200,000 annual cases internationally, the PERKAT system is both catheter-based and self-expanding, offering optimal support without the need for invasive procedures.
Furthermore, the PERKAT technique operates in synchrony with the heart’s rhythm, ensuring a natural and high-performing circulatory support system. Notably, NovaPump’s innovative solution is yet to make its debut in the market; nevertheless, relevant scientific studies and high-profile conferences continue to highlight their credible development status and clear technological and medical advantages.
NovaPump is undeniably revolutionizing the way we approach cardiac care, signalling a promising future in the industry of medical innovations. The breakthrough and advancements it brings into the healthcare system do not merely save lives – they also provide a significantly enhanced quality of life for those grappling with cardiac ailments. As the healthcare scenery consistently evolves, the expansion and growth of NovaPump is expected to continue touching newer horizons.
The company aims to serve the immediate needs of left or right heart patients in the coming years further, revolutionizing cardiovascular care. For more information about NovaPump, you can visit their website at www.novapump.com or check out their company profile on LinkedIn at www.linkedin.com/company/novapump-gmbh/about.
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
